MedTrace Logo

Polymorphisms and Busulfan Pharmacokinetic Study

NCT01257854 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-04-28

No results posted yet for this study

Summary

Test the correlations between the pharmacogenetic and pharmacokinetic of Busulfan IV in children receiving hematopoietic stem cell transplantation.

Conditions

  • Children Who Receive a Stem Cell Transplantation With Busulfan IV

Sponsors & Collaborators

  • European Society for Blood and Marrow Transplantation

    collaborator NETWORK

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Marc Ansari, MD, PhD · Hopital Cantonal de Genève, Switzerland

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Canada
  • France
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01257854 on ClinicalTrials.gov